ERBB3 mutation + TMB-H	Non Small Cell Lung Cancer	ERBB3 mutation + TMB-H	Non Small Cell Lung Cancer	gefitinib Sensitive: C3 – Early Trials gefitinib Sensitive : C3	gefitinib Sensitive: C3 – Early Trials gefitinib Sensitive : C3
ERBB3 mutation + TMB-H	Bladder Cancer	ERBB3 mutation + TMB-H	Bladder Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3

ERBB3 mutation + TMB-H

Associations